Trial
NCT01468636
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of British Columbia
Collaborators
British Columbia Centre for Disease Control
Condition
Genital Warts
Intervention
Oral Zinc
Why stopped
There was no clear benefit but numerous side effects.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-11-02